Cytodyn Inc (CYDY)

[Saltz]

The headwinds have been mounting on the financial front w Nader’s shift to going all in on the Covid play.

Make no mistake both the SC Interim and full trial results will have tremendous impact on the future of CYDY. This result will be a pivot North or South, a black and white scenario.

If Covid busts the coffers are going to be stressed at a level not seen before.

The failure to secure BLA acceptance for the past year has been a gaff that has pushed any possibility of revenue w/o the Covid play into Q4 2021 and that would be on Nader’s optimistic timeline. The reality is Q1 2022 is best case.

I agree w Nader’s emphasis on the Covid play given the strength of the data and the SP is proof he made the right move. His mistake was not securing the BLA as his number one priority in the process. Now time is his enemy everywhere he looks in regards to Covid and the BLA.

At 800M A/S options will tighten up w/o major news. Then we sink into the likelihood of a R/S and the slow bleed is on.

I thank Nader for taking this company from sub .30 to $10 in 2020. The SP is currently up 1000% and lest longtime longs forget where we came from. It’s a tough road fraught w difficult landscape to make it to the big time no matter how disruptive the science.

If Nader could see and accept his deficiencies CYDY would most likely be in a much more advantageous position. It’s now become a binary event w all eyes on the S/C data.